Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Bayer AG by Quarter
Bayer AG (Adempas & Verquvo sGC Cardiovascular Alliance) — Intangible asset amortization in Cost of Sales ($M) ($M)
Merck Bayer AG: $0M in Q4 2021. No newer figure appears in the documents we track.
Where the Q4 2021 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: Form 10-K (filed 2024-02-26) ↗
Reported in Form 10-Q / 10-K Note 3/4 Collaborative Arrangements.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Bayer AG (Adempas & Verquvo sGC Cardiovascular Alliance) — Intangible asset amortization in Cost of Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2021 | Dec 31, 2021 | 0 | – | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2021 | Sep 30, 2021 | 0 | – | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 153 | – | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 153 | – | Form 10-Q (filed 2022-05-05) ↗ |
Cite this data
StockData. (2026). Merck Bayer AG ($M), quarterly Q1 2021–Q4 2021 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/collab-bayer-amort
See every metric in the Merck KPI table. Data updated Oct 26, 2026.